Sport Pfizer / Biontech will produce 100 million doses per year in South Africa

05:20  22 july  2021
05:20  22 july  2021 Source:   rfi.fr

Australia falling behind in securing Pfizer booster shots

  Australia falling behind in securing Pfizer booster shots As other countries cement deals with Pfizer for the years ahead, Australia is banking on a Novavax order and awaiting advice on what else might be needed.Australia has fallen behind Europe and North America in securing more supplies of the Pfizer vaccine for future years, as nations start buying booster shots to prepare for new coronavirus strains.

Pfizer/BioNTech a trouvé un accord avec Biovac pour produire 100 millions de doses de son vaccin chaque année dans une usine du Cap en Afrique du Sud. © Reuters - Dado RUVIC Pfizer / Biontech has found an agreement with BioVac to produce 100 million doses of its vaccine each year in a Cape Town factory in South Africa.

After Johnson & Johnson allied to Aspen, it is the turn of Pfizer / Biontech to associate with a South African company to produce their anti-Covid vaccine. The Manufacturer signed an agreement with the BioVac Institute, a semi-state company installed in Cape Town. This will be the first time that a messenger RNA vaccine is produced in Africa. Objective: 100 million doses per year by 2023. Production could begin next year. Pfizer says he wants to reserve these vaccines for the African continent.

Children as young as 12 could be vaccinated in Australia

  Children as young as 12 could be vaccinated in Australia Australia's drug regulator, the TGA, is currently assessing an application from Pfizer to have its jab approved in the country for that age group. The vaccine has already been approved for children over 12 in countries such as the US, Canada, Germany, Japan, France and Italy. © Provided by Daily Mail ( Trials for children under 12 are ongoing to determine safety and dosage, with results due in a few months and a decision in the US expected in early 2022. NSW Premier Gladys Berejiklian said vaccinating teenagers was crucial to securing freedom.

Vaccines produced in Africa exclusive of Africans. It's all the originality of the Pfizer offer. For the continent, the advantage is to reduce its dependence to foreign countries. It is remembered that in March, the Serum Institute of India had suspended the export of the AstraZeneca vaccine. India, struck by a devastating epidemic wave, then wanted to focus on its national demand. However, the African continent, via the Covax device, had made this laboratory one of its main suppliers.

This kind of disappointment should be avoided with a production reserved for Africans. On the other hand, the continent will still have to rely on the outside. It is an agreement of "Fill and Finish" which binds companies, reports our correspondent to Johannesburg, Romain song . The ingredients will be imported from Europe and assembled in South Africa. The two laboratories thus keep hand on the elaboration of the messenger RNA, since the serum will be transported from their European factories. It will therefore be set in vials and distributed exclusively within the 55 African Union member countries. A great and good news for the African Center for Disease Prevention and Control.

What you need to know about mixing COVID vaccines

  What you need to know about mixing COVID vaccines Several countries have approved mixing COVID vaccines as they seek to boost their inoculation campaigns.Mixing vaccines means administering one brand of vaccine for a patient’s first shot, followed by a vaccine made by a different manufacturer for the second dose. Proponents of the policy believe it can increase the speed and effectiveness of vaccination campaigns.

Video: Pfizer vaccines soon products in South Africa (euronews)

The agreement is far from the ambitions of President Cyril Ramaphosa who battle in front of the World Trade Organization to force the Manufacturers to share The recipe of their vaccines. While several emerging countries and NGOs plead for the suspension of patents to allow massive production of vaccines, large laboratories are reluctant to transmit their know-how. "Weaken intellectual property will only discourage innovation," says Albert Bourla, Pfizer CEO.

Despite this disagreement, President Ramaphosa described this partnership for "major progress to overcome immunization inequality".

The first step in the process will be the transfer - from now on - technologies to South Africa and the installation of equipment adapted to the premises of BioVac. According to the schedule announced: At the end of this year, the site of the city of CAP must be able to distribute Pfizer / Biontech vaccines to the different countries of the continent.

The next step will be the conditioning party, that is to say the vial of the serum delivered by the two laboratories which must be able to start next year and in the long term, exit South African factories from BioVac the 100 million annual doses advertised and intended only for African countries.

US sends half million Covid vaccines to Jordan .
Half a million Covid-19 vaccines began shipping Thursday from the United States to Jordan in the latest stage of a global US effort to overcome the pandemic, officials said. A senior White House official told AFP: "500,000 doses of Pfizer will begin to be shipped to Jordan from the United States. These doses arrive in Jordan on Saturday." According to the official, who spoke on condition of anonymity, the doses are being sent in a direct arrangement with Jordan, rather than through the international Covax program."We are proud to be able to deliver these safe and effective vaccines to the people of Jordan," the official told AFP.

usr: 0
This is interesting!